InnoCan Pharma Corporation (CSE:INNO)
15.39
-0.31 (-1.97%)
Nov 19, 2025, 1:43 PM EST
InnoCan Pharma Market Cap
InnoCan Pharma has a market cap or net worth of CAD 92.91 million as of November 21, 2025. Its market cap has increased by 54.19% in one year.
Market Cap
92.91M
Enterprise Value
88.31M
Revenue
39.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.39
Market Cap Chart
Since September 25, 2019, InnoCan Pharma's market cap has increased from 1.06M to 92.91M, an increase of 8,644.84%. That is a compound annual growth rate of 106.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 92.91M | 54.19% |
| Dec 31, 2024 | 60.26M | -27.47% |
| Dec 29, 2023 | 83.08M | 54.74% |
| Dec 30, 2022 | 53.69M | -72.99% |
| Dec 31, 2021 | 198.79M | 218.14% |
| Dec 31, 2020 | 62.49M | 171.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Loblaw Companies | 72.50B |
| Dollarama | 53.39B |
| George Weston | 36.16B |
| Metro | 21.24B |
| Saputo | 15.83B |
| Empire Company | 11.97B |
| Premium Brands Holdings | 4.04B |
| Maple Leaf Foods | 3.16B |